Clinical Trials Sponsored by M.D. Anderson Cancer Center

Total 3791 results

M.D. Anderson Cancer Center

Completed

Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study

Pain | Solid Tumors

United States
M.D. Anderson Cancer Center

Completed

Olanzapine in Patients With Advanced Cancer and Weight Loss

Weight Loss | Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Valproic Acid and Bevacizumab in Patients With Advanced Cancer

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

Endometrial Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

18-F-Fluoroacetate as PET Imaging Agent

Breast Cancer | Prostate Cancer | Brain Cancer
M.D. Anderson Cancer Center

Completed

Erwinase Study in Patients With Acute Lymphoblastic Leukemia

Leukemia

United States
M.D. Anderson Cancer Center

Terminated

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Osteosarcoma

United States
M.D. Anderson Cancer Center

Completed

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide

Esophageal Cancer | Lung Cancer | Gastrointestinal Disease

United States
M.D. Anderson Cancer Center

Completed

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

Dyspnea | Advanced Cancers

United States
M.D. Anderson Cancer Center

Withdrawn

Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation

Esophageal Cancer
M.D. Anderson Cancer Center

Terminated

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

Leukemia | Pediatric Cancer

United States
M.D. Anderson Cancer Center

Completed

Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Terminated

Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)

Leukemia

United States
M.D. Anderson Cancer Center

Withdrawn

PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation

Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center

Completed

A Study for Leukemia Patients With Life-Threatening Infections

Leukemia

United States
M.D. Anderson Cancer Center

Completed

Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder

Bladder Cancer

United States
M.D. Anderson Cancer Center

Completed

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

Breast Cancer | Invasive Breast Carcinoma | Metastatic Breast Carcinoma

United States
M.D. Anderson Cancer Center

Withdrawn

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

Leukemia
M.D. Anderson Cancer Center

Terminated

Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients

Infection

United States
M.D. Anderson Cancer Center

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Completed

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

Peritoneal Cancer

United States
M.D. Anderson Cancer Center

Terminated

Melatonin Postoperative Sleep Study in Breast Cancer Patients

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor

Solid Tumors

United States
M.D. Anderson Cancer Center

Completed

Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer

Head and Neck Cancer | Skin Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Cutaneous T-cell Lymphoma
M.D. Anderson Cancer Center

Withdrawn

Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema

Head and Neck Cancer | Lymphedema | Oral Cancer | Oropharyngeal Cancer
M.D. Anderson Cancer Center

Completed

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Lymphoma | Leukemia

United States
M.D. Anderson Cancer Center

Terminated

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrome (MDS) Patients

Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Terminated

Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets

Lymphoma | Leukemia

United States
M.D. Anderson Cancer Center

Completed

Pain Quantification and Pain Management in Interventional Radiology (IR)

Pain

United States
M.D. Anderson Cancer Center

Completed

Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Axillary Reverse Mapping for Invasive Carcinoma of the Breast

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

Leukemia

United States
M.D. Anderson Cancer Center

Completed

Lymphoscintigraphy in Patients With Vaginal Cancer

Vaginal Cancer

United States
M.D. Anderson Cancer Center

Terminated

Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA

Brain Tumors | Central Nervous System Tumors

United States
M.D. Anderson Cancer Center

Completed

Development of the MDASI-Spine Tumor Module

Spinal Cord Tumor

United States
M.D. Anderson Cancer Center

Completed

Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Withdrawn

Functional Outcomes Following Limb Sparing Surgery for Sarcoma Patients

Sarcoma

United States
M.D. Anderson Cancer Center

Completed

Asian Youth and Tobacco Control Survey

Smoking | Tobacco Use

United States
M.D. Anderson Cancer Center

Completed

Questionnaire and Fall Risk Assessment

Prostate Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole

Head and Neck Neoplasms | Metastases, Neoplasm | Squamous Cell Carcinoma

United States
M.D. Anderson Cancer Center

Completed

Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

Liver Cancer

United States
M.D. Anderson Cancer Center

Terminated

Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

School Reintegration Outcomes in Pediatric Cancer Patients

Pediatric Cancers

United States
M.D. Anderson Cancer Center

Completed

LY2275796 in Advanced Cancer

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients

Colorectal Cancer

United States
M.D. Anderson Cancer Center

Completed

M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program

Heart Failure | Cancer

United States

Clinical Trials Sponsored by M.D. Anderson Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations